Small Molecules
7 January 2020
InxMed Announces Clinical Collaboration with MSD to Evaluate IN10018 in Combination with Pembrolizumab7 January 2020
Oxurion NV Reports Positive Topline Data from Phase 1 study evaluating THR-687 for treatment of DME6 January 2020
ESCAPE Bio Announces Excellent Safety and Tolerability in Phase 1 Study of Oral S1P5 Receptor Agonist ESB16096 January 2020
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline Validated by European Medicines Agency6 January 2020
Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction3 January 2020
Incyte Announces Results of Phase 3 Study of Itacitinib in Patients with Treatment-Naïve Acute Graft-Versus-Host Disease2 January 2020
Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study in Palmoplantar Keratoderma (PPK)2 January 2020
DURECT Corporation Announces Top-Line Results from Phase 2a Clinical Trial in Patients with Psoriasis1 January 2020
Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder30 December 2019
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Vulgaris30 December 2019
Commencement of phase 1 trial for AZD0466 utilising DEP30 December 2019
Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer24 December 2019
Allergan Receives U.S. FDA Approval for UBRELVY™ for the Acute Treatment of Migraine with or without Aura in Adults23 December 2019
Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder23 December 2019
FDA Approves Intra-Cellular Therapies’ Novel Antipsychotic, CAPLYTA® (lumateperone) for the Treatment of Schizophrenia in AdultsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports